Medications
FDA approves new sleeping drug from Merck (Update)
Merck & Co. Inc. has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep.
Aug 13, 2014
0
0
News tagged with merck
HIV & AIDS
Fecal microbiota tx feasible for recurrent C. difficile in HIV
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Internal Medicine.
May 22, 2013
0
0
Medications
FDA backs Vytorin for kidney disease patients
(AP) -- The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.
Oct 31, 2011
0
0
Other
Merck's global sales jump 12% in second quarter
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations.
Jul 30, 2019
0
3
Diseases, Conditions, Syndromes
Natural language processing helps identify patients with chronic cough
Researchers from Regenstrief Institute, Indiana University School of Medicine and Merck & Co. created and validated a natural language processing (NLP) algorithm to identify patients with chronic cough. The validation paper, ...
Feb 9, 2021
0
8
Cardiology
Risk of sudden cardiac death up for black patients with HTN
(HealthDay) -- Black patients with hypertension face a significantly increased risk of sudden cardiac death (SCD) compared with nonblack patients, even after adjusting for multiple confounding variables, according to a study ...
Apr 13, 2012
0
0
Diabetes
Less than half of new diabetes patients achieve A1C goals
(HealthDay) -- Less than half of newly diagnosed patients with type 2 diabetes achieve A1C
Feb 28, 2012
0
0
Oncology & Cancer
Experimental cervical cancer vaccine looks promising in trial
(HealthDay)—An experimental vaccine meant to protect against nine types of human papillomavirus (HPV) could prevent 90 percent of all cervical cancers, a new study suggests.
Oct 1, 2014
0
0
Medications
Merck, Sanofi Pasteur ending JV to market vaccines in Europe
Merck and Sanofi Pasteur are ending their partnership, begun in 1994, to market the drugmakers' vaccines in Europe.
Mar 8, 2016
0
0
Medications
Merck continuing study of cholesterol drug in new class
Merck & Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent ...
Nov 13, 2015
0
21
